Even though a minority of ALS patients will be eligible for participation in the current trial due to need of homozygosity for the C-allele at SNP rs12608932 in UNC13A, there are several aspects of the trial that will hopefully ensure prompt enrolment. The gene discussed is UNC13A; the disease is amyotrophic lateral sclerosis.